Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,231,834 | 3,771,083 | 3,186,470 | 3,010,108 | 1,370,816 |
| Depreciation Amortization | 1,036,568 | 3,259,923 | 2,781,983 | 1,499,375 | 696,187 |
| Accounts receivable | N/A | 380,814 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -228,744 | N/A | N/A | N/A |
| Other Working Capital | -1,763,300 | 327,142 | 955,941 | -1,172,491 | -769,737 |
| Other Operating Activity | -62,975 | 865,138 | -1,429,359 | -723,183 | -82,426 |
| Operating Cash Flow | $1,442,127 | $8,375,356 | $5,495,035 | $2,613,809 | $1,214,840 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,709 | 2,905,945 | 2,990,079 | 2,866,229 | 1,342,918 |
| PPE Investments | -260,717 | -1,704,719 | -1,106,811 | -690,369 | -313,221 |
| Net Acquisitions | -1,008,859 | -1,106,661 | -989,757 | -960,458 | -915,568 |
| Purchase Of Investment | N/A | N/A | -54,625 | N/A | N/A |
| Purchase Sale Intangibles | -206,558 | -1,855,511 | -1,126,320 | -538,917 | -365,213 |
| Other Investing Activity | -143,584 | -1,665,104 | -981,952 | -431,638 | -303,076 |
| Investing Cash Flow | $-1,440,868 | $-1,570,539 | $-143,066 | $783,764 | $-188,947 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 74,311 | 339,921 | -810,274 | -93,395 | N/A |
| Debt Issued | 2,541,671 | 1,373,743 | N/A | N/A | N/A |
| Debt Repayment | N/A | -2,063,809 | N/A | N/A | N/A |
| Common Stock Issued | 15,114 | 25,558 | 26,012 | 23,980 | 22,826 |
| Common Stock Repurchased | -311,097 | N/A | N/A | N/A | N/A |
| Dividend Paid | -770,814 | -3,123,188 | -2,382,699 | -1,539,762 | -720,281 |
| Other Financing Activity | -468,534 | -2,591,580 | -1,884,569 | -1,727,815 | -646,731 |
| Financing Cash Flow | $1,080,651 | $-6,039,355 | $-5,051,530 | $-3,336,992 | $-1,344,186 |
| Exchange Rate Effect | -13,855 | -69,007 | -79,337 | -34,077 | -24,094 |
| Beginning Cash Position | 4,286,079 | 3,652,238 | 3,717,115 | 3,607,082 | 3,624,230 |
| End Cash Position | 5,354,134 | 4,348,694 | 3,938,217 | 3,633,586 | 3,281,843 |
| Net Cash Flow | $1,068,056 | $696,456 | $221,102 | $26,504 | $-342,387 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,442,127 | 8,375,356 | 5,495,035 | 2,613,809 | 1,214,840 |
| Capital Expenditure | -261,976 | -1,787,782 | -1,112,013 | -694,155 | -314,489 |
| Free Cash Flow | 1,180,151 | 6,587,574 | 4,383,022 | 1,919,654 | 900,351 |